NCT07246928Completed
Ultraspound-guided Intralesional Injection of Cystic Hygroma - A Case Report
Ultrasound-guided Intralesional Injection of Cystic Hygroma - A Case Report
Source: ClinicalTrials.gov · Last updated 30 Apr 2026
Brief summary (registry, in English)
Ultrasound-guided Intralesional Injection of Cystic Hygroma - A Case Report
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1 (actual)
- First submitted
- 19 Nov 2025
- Start date
- 1 Sept 2024
- Primary completion date
- 1 Sept 2025
- Lead sponsor
- Delta University for Science and Technology
- NCT number
- NCT07246928
What you commit to
- Study type: Interventional
- Participants enrolled: 1
- From 1 Sept 2024 to the primary completion date, 1 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Pediatric patients of age up to 12 years having cystic hygromas (macrocystic lymphatic malformations), from the vascular anomalies clinic at the pediatric surgery department in Cairo University Specialized Pediatric Hospital (Abu EL-Reesh hospital). -
Age in the registry: 1 month to 12 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Specialized Pediatric Hospital (Abu EL-Reesh Japanese hospital) Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.